Egawa K, Tanino T
Int J Cancer. 1976 Jun 15;17(6):725-9. doi: 10.1002/ijc.2910170606.
Immunity against transplantation of MM2 cells, an ascites cell line of mouse mammary carcinoma, was induced in syngeneic C3H/He mice by intraperitoneal injection of a complex formed between a MM2-specific surface component isolated from the cells and a serum factor found in the serum from MM2-regressor and MM2-bearing mice. The induced immunity was transferable to other mice with the spleen cells or with the serum from the immunized animals. This cell surface component was not immunogenic by itself. A new immunogenicity was induced in the protein moiety of this substance when the serum factor was bound to the polysaccharide-containing part of the molecule. On the basis of these results, a biphasic mechanism for the induction of the humoral immunity against tumor antigens was proposed. The first phase takes place in tumor-bearing animals and gives rise to the serum factor. The second phase, which is blocked in tumor-bearing animals, consists of the induction of the humoral immunity by the complex in tumor-free animals.
通过向同基因C3H/He小鼠腹腔注射从MM2细胞(一种小鼠乳腺癌腹水细胞系)中分离出的MM2特异性表面成分与MM2消退小鼠和携带MM2小鼠血清中发现的一种血清因子形成的复合物,诱导了对MM2细胞移植的免疫。诱导的免疫可以通过免疫动物的脾细胞或血清转移到其他小鼠。这种细胞表面成分本身没有免疫原性。当血清因子与该分子含多糖部分结合时,该物质的蛋白质部分诱导产生了新的免疫原性。基于这些结果,提出了诱导针对肿瘤抗原的体液免疫的双相机制。第一阶段发生在荷瘤动物中并产生血清因子。第二阶段在荷瘤动物中受阻,包括在无瘤动物中由复合物诱导体液免疫。